LGBTQ+ Healthcare Needs
This webinar occurred on October 21, 2020, and expires on October 22, 2021
Join the Washington Medical Commission for an educational opportunity on LGBTQ+ Health Care Needs. The webinar will cover:
- Creating a welcoming and inclusive practice for LGBTQ+ patients.
- The social and cultural barriers to health faced by LGBTQ+ patients.
- Feel comfortable addressing the unique needs of LGBTQ+ patients.
- Understand the basics of primary care for transgender patients.
Upon completion of this educational activity, participants should be able to:
- Assess the unique needs of LGBTQ+ patients.
- Distinguish the primary care needs for transgender patients.
- Lessen the patient fear due to stigma, discrimination, and institutional bias in the health care system.
This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.
Diana Currie, MD
Dr. Diana Currie is a faculty member of the Providence St. Peter Family Medicine Residency department in Olympia, WA. Board certified in Obstetrics & Gynecology, she has been teaching medical students and residents since 1997. Dr. Currie has a B.A. in philosophy and computer science from the University of California, Berkeley. She attended Harvard Medical School where she received an Albert Schweitzer Fellowship in Adolescent Gynecology in underserved populations. Her longstanding interest in hormones began with her work in the endocrinology of puberty and encompasses reproduction, menopause and transgender hormone management. She began treating gender non-conforming and transgender patients in 2000, long before there was a national spotlight on transgender people. Dr. Currie has presented her work in the field of transgender medicine at national medical conferences. She has given seminars in transgender healthcare and provided expertise and education for many organizations including the Washington Attorney General’s office and the American Catholic Healthcare Association. She is the Director of Quality for Providence Medical Group and a member of the Washington Medical Commission where she advocates for equitable delivery of safe, high quality healthcare for all Washingtonians. Her philosophy is always to try to meet the patient where they are and help safely care for them on their unique journey, while teaching the next generation of physicians.
Chelsea D. Unruh, MD
Dr. Unruh is originally from Hilsboro, Oregon. They completed an undergraduate degree in English at Westmont College in Santa Barbara, California. After teaching English abroad, Dr. Unruh returned home to complete post-baccalaureate studies at Portland State University. They received medical training at Poznan University of Medical Sciences in Poznan, Poland and completed residency at Providence St. Peter Family Medicine in Olympia. They are board-certified by the American Board of Family Medicine. Dr. Unruh is also an active member of the Washington Academy of Family Physicians, Washington State Medical Association, American Academy of Family Physicians, and the Gay and Lesbian Medical Association. They are the current Past President of the Thurston Mason County Medical Society. They are in private practice at Yelm Family Medicine providing Primary Care with OB and have a solo practice providing transgender specific care at Unruhly Medicine at the Rainbow Health Center in Olympia.
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Alden Roberts, MD
Washington Medical Commission
This learning activity is not funded by any commercial entity.
However, the Washington Medical Commission gratefully acknowledges the unrestricted educational grant from the FSMB Foundation in the amount of $10,000 to support this activity.
Disclosure of Commercial Interest
As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity and promote improvements or quality in healthcare. All persons in the position to control the content of an education activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients.
The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity.
The speakers, course director and planners at the Federation of State Medical Boards and the Washington Medical Commission have no relevant financial interests to disclose.
Disclosure of Unlabeled Uses
Name of Speaker: Diana Currie, MD
Drugs/Products to be Referenced: Hormones used for transition. Use based on nationally accepted evidence-based guidelines.
Name of Speaker: Chelsea D. Unruh, MD
Drugs/Products to be Referenced: Estradiol, testosterone (non FDA approved uses)
No other speakers or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.